{"id":5601,"date":"2025-09-01T11:31:47","date_gmt":"2025-09-01T11:31:47","guid":{"rendered":"http:\/\/www.esgbureau.com.tw\/taiwan\/?p=5601"},"modified":"2025-11-13T00:42:01","modified_gmt":"2025-11-12T16:42:01","slug":"polaris","status":"publish","type":"post","link":"https:\/\/www.esgbureau.com.tw\/en\/articles\/polaris\/","title":{"rendered":"Polaris Pharma ESG Expands New Drug R&amp;D Capabilities"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-2\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><div class=\"wpb_animate_when_almost_visible wpb_fadeInUp fadeInUp wpb_column vc_column_container vc_col-sm-8\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column wpb_content_element\" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<blockquote><p>\n\u5c08\u5229\u4fdd\u8b77\u667a\u8ca1\u6b0a\u6210\u679c \u5317\u6975\u661f\u85e5\u696dESG\u64f4\u5927\u65b0\u85e5\u7814\u767c\u80fd\u91cf\n<\/p><\/blockquote>\n\n\t\t<\/div>\n\t<\/div>\n\n\t<div class=\"wpb_text_column wpb_content_element\" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<p>Polaris is committed to the research and development of metabolic therapy cancer drugs to alleviate patients' discomfort and reduce treatment side effects. In 2022, the company will reach the milestone of blindness for mesothelial lung cancer, and many other cancers will enter Phase III clinical trials, and move toward obtaining national drug certificates. In addition, the company will also undertake the commissioned development and production of biopharmaceuticals (CDMO) services, and will increase its investment in research and development year by year, and will introduce an automated management system to monitor and control energy consumption in the future, In the future, we will introduce an automated management system to monitor energy consumption and hire more employees to expand our influence as a sustainable employer, so that we can walk side by side with the public on the road of new drug research and development in the long term.<!--more--><\/p>\n\n\t\t<\/div>\n\t<\/div>\n<div class=\"vc_empty_space\"   style=\"height: 40px\"><span class=\"vc_empty_space_inner\"><\/span><\/div>\n\t<div class=\"wpb_text_column wpb_content_element\" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<blockquote><p>\n\u7814\u767c\u6295\u5165\u9010\u5e74\u4e0a\u5347\u3000\u5c08\u5229\u4fdd\u8b77\u667a\u6167\u8ca1\u7522\u6b0a\u6210\u679c\n<\/p><\/blockquote>\n\n\t\t<\/div>\n\t<\/div>\n<div class=\"vc_empty_space\"   style=\"height: 40px\"><span class=\"vc_empty_space_inner\"><\/span><\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container vc_col-sm-2\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/div><div class=\"vc_row wpb_row vc_row-fluid vc_custom_1736534461966\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><\/div><\/div><\/div><\/div><!-- Row Backgrounds --><div class=\"upb_bg_img\" data-ultimate-bg=\"url(https:\/\/www.esgbureau.com.tw\/taiwan\/wp-content\/uploads\/2025\/01\/section-bg-21.jpg)\" data-image-id=\"id^1043|url^http:\/\/www.esgbureau.com.tw\/taiwan\/wp-content\/uploads\/2025\/01\/section-bg-21.jpg|caption^null|alt^null|title^section-bg-21|description^null\" data-ultimate-bg-style=\"vcpb-vz-jquery\" data-bg-img-repeat=\"no-repeat\" data-bg-img-size=\"cover\" data-bg-img-position=\"\" data-parallx_sense=\"30\" data-bg-override=\"ex-full\" data-bg_img_attach=\"scroll\" data-upb-overlay-color=\"\" data-upb-bg-animation=\"\" data-fadeout=\"\" data-bg-animation=\"left-animation\" data-bg-animation-type=\"h\" data-animation-repeat=\"repeat\" data-fadeout-percentage=\"30\" data-parallax-content=\"\" data-parallax-content-sense=\"30\" data-row-effect-mobile-disable=\"true\" data-img-parallax-mobile-disable=\"true\" data-rtl=\"false\"  data-custom-vc-row=\"\"  data-vc=\"8.5\"  data-is_old_vc=\"\"  data-theme-support=\"\"   data-overlay=\"false\" data-overlay-color=\"\" data-overlay-pattern=\"\" data-overlay-pattern-opacity=\"\" data-overlay-pattern-size=\"\"    ><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Polaris Pharmaceuticals focuses on developing metabolic therapy drugs for cancer to alleviate patient discomfort and reduce side effects. In 2022, the company achieved a milestone by completing its clinical trial for lung mesothelioma, and several of its cancer drugs have entered Phase III clinical trials, moving towards obtaining drug approvals in various countries. In addition, the company undertakes contract development and manufacturing organization (CDMO) services for biopharmaceuticals, and its R&amp;D investment has been increasing year by year. In the future, it will implement an automated management system to monitor energy consumption.<\/p>","protected":false},"author":1,"featured_media":5602,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[57],"tags":[75,61,73,81,69,79,77],"class_list":["post-5601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-cdmo","tag-esg","tag-73","tag-81","tag-69","tag-79","tag-77"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/posts\/5601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/comments?post=5601"}],"version-history":[{"count":12,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/posts\/5601\/revisions"}],"predecessor-version":[{"id":6764,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/posts\/5601\/revisions\/6764"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/media\/5602"}],"wp:attachment":[{"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/media?parent=5601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/categories?post=5601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.esgbureau.com.tw\/en\/wp-json\/wp\/v2\/tags?post=5601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}